NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bioasis Technologies Inc (V: BTI)

 
BTI Technical Analysis
1
As on 24th Dec 2024 BTI STOCK Price closed @ 1.21 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BTISTOCK Price

Open 1.22 Change Price %
High 1.23 1 Day N/A N/A
Low 1.21 1 Week 0.00 0.00
Close 1.21 1 Month 0.00 0.00
Volume 77460 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
V Canada Most Active Stocks
SML 1435.70 0.53%
NU 10.36 -26.32%
YTY 0.04 %
LAB 0.12 9.09%
SNS 0.40 -2.44%
ROS 0.08 -11.11%
NBY 0.08 -27.27%
FLT 0.59 -1.67%
HIVE 3.04 2.70%
LIS 0.31 24.00%
 
V Canada Top Gainers Stocks
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
BST 33.38 83350.00%
 
V Canada Top Losers Stocks
TKU 0.00 -100.00%
TKU 0.00 -100.00%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
AAA-P 0.06 -57.14%
 
 
BTI
Daily Charts
BTI
Intraday Charts
Whats New @
Bazaartrend
BTI
Free Analysis
 
BTI Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
BTI Forecast July 2025
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
BTI Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
BTI Forecast2025
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
BTI Other Details
Segment EQ
Market Capital 20561040.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BTI Address
BTI
 
BTI Latest News
 
Your Comments and Response on Bioasis Technologies Inc
 
BTI Business Profile
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). Bioasis Technologies Inc. has research collaborations with Aposense Limited to focus on the delivery of siRNA into the brain; and Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane's OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain. The company was incorporated in 2006 and is headquartered in New Haven, Connecticut. Address: 157 Church Street, New Haven, CT, United States, 06510
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service